CuraSen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing drug candidates with broad applicability in ...
Priscilla Timmons was facing a 10% chance of surviving a massive blood clot when a golden retriever named Scrunchie woke her up from a coma.
Children's Hospital Colorado reports a 73% rise in patients who used its Eating Disorders Program over the last year.
Theravance is educating physicians and payers in anticipation of phase 3 data on ampreloxetine in nOH due to MSA. The company ...
Patients with presyncope and those with syncope in the ED have similar 30‑day serious cardiac outcomes, although patients ...